Oncology & Cancer
Study identifies causes of cancer
A team of Yale-led researchers can now quantify the factors causing changes in the DNA that contribute most to cancer growth in tumors of most major tumor types.
Apr 27, 2022
0
412
Page 12 - News tagged with prostate cancers
Oncology & Cancer
Doctors suggest new names for low-grade prostate cancer
A cancer diagnosis is scary. Some doctors say it's time to rename low-grade prostate cancer to eliminate the alarming C-word.
Apr 18, 2022
0
148
Medical research
Newly developed genetic risk scores could help patients, physicians make health decisions
A person's risk of developing diseases such as type 2 diabetes or breast cancer may be influenced by thousands of genetic differences. Looking at a single DNA difference that has a small effect on risk may not be clinically ...
Apr 18, 2022
0
85
Oncology & Cancer
Researchers reveal strategies for advanced prostate cancer treatment
In a study published in Cell Reports Medicine, a group of Chinese scientists revealed the oncometabolite role of progesterone in advanced prostate cancer and strategies to eliminate its oncogenic effect as an aspect of prostate ...
Mar 15, 2022
0
62
Oncology & Cancer
Metastatic prostate cancer on the rise since decrease in cancer screenings
A new study from Keck Medicine of USC finds that the incidence rate of metastatic prostate cancer has significantly increased for men 45 and older and coincides with recommendations against routine prostate cancer screenings.
Mar 14, 2022
0
68
Oncology & Cancer
Optimizing balance of treatments in prostate cancer
Patients receiving radiotherapy to treat high-risk prostate cancer also benefit from androgen deprivation therapy. The ideal duration of treatment may be roughly two years if receiving external beam radiation and one year ...
Feb 28, 2022
0
53
Oncology & Cancer
Scientists target protein to lower risk of prostate cancer spread
Targeting a specific protein that is often overexpressed in prostate cancer can help prevent or delay the disease from spreading to other parts of the body, according to a study led by Cedars-Sinai Cancer investigators.
Feb 25, 2022
0
93
Medications
Three-drug combination prolongs survival in men with metastatic, hormone-sensitive prostate cancer
Results from an international, randomized, double-blind, placebo-controlled, phase 3 clinical trial indicate that adding the androgen-receptor inhibitor darolutamide to androgen-deprivation therapy and chemotherapy prolongs ...
Feb 18, 2022
0
79
Medications
Widely-used hormone drug associated with increased risk of benign brain tumor at high doses
High doses of a widely-used drug used in the hormonal treatment of conditions such as excessive hair growth, early puberty, prostate cancer, are linked to an increased risk of meningioma—the most common type of benign ...
Feb 4, 2022
1
236
Oncology & Cancer
Speeding up cancer biomarker detection for point of care diagnostics
The detection and quantification of cancer-associated molecular biomarkers in body fluids, or liquid biopsies, prove minimally invasive in early cancer diagnostics. Researchers at the University of Illinois Urbana-Champaign ...
Jan 28, 2022
0
63
